Pereda Javier, Sabater Luis, Cassinello Norberto, Gómez-Cambronero Luis, Closa Daniel, Folch-Puy Emma, Aparisi Luis, Calvete Julio, Cerdá Miguel, Lledó Salvador, Viña José, Sastre Juan
Department of Physiology, University of Valencia, Spain.
Ann Surg. 2004 Jul;240(1):108-16. doi: 10.1097/01.sla.0000129343.47774.89.
To assess the effects of inhibiting both tumor necrosis factor (TNF)-alpha production and xanthine oxidase activity on the inflammatory response, mitogen-activated protein kinase (MAPK) activation and mortality in necrotizing acute pancreatitis in rats.
Pancreatic injury triggers 2 major pathways involved in the systemic effects of severe acute pancreatitis: pro-inflammatory cytokines and oxidative stress.
Pancreatitis was induced by intraductal infusion of 3.5% sodium taurocholate. We examined whether treatment with oxypurinol, a specific inhibitor of xanthine oxidase, and/or pentoxifylline, an inhibitor of TNF-alpha production, affects pancreatic damage, ascites, lung inflammation, and MAPK phosphorylation.
Oxypurinol prevented p38 phosphorylation in the pancreas and partially avoided the rise in lung myeloperoxidase activity. Pentoxifylline prevented erk 1/2 and JNK phosphorylation in the pancreas, and it partially reduced ascites and the rise in lung myeloperoxidase activity. Combined treatment with oxypurinol and pentoxifylline almost completely abolished ascites, MAPK phosphorylation in the pancreas, and the increase in lung myeloperoxidase activity. Histology revealed a reduction in pancreatic and lung damage. These changes were associated with a significant improvement of survival.
: Simultaneous inhibition of TNF-alpha production and xanthine oxidase activity greatly reduced local and systemic inflammatory response in acute pancreatitis and decreased mortality rate. These effects were associated with blockade of the 3 major MAPKs.
评估抑制肿瘤坏死因子(TNF)-α生成和黄嘌呤氧化酶活性对大鼠坏死性急性胰腺炎炎症反应、丝裂原活化蛋白激酶(MAPK)激活及死亡率的影响。
胰腺损伤引发了严重急性胰腺炎全身效应所涉及的两条主要途径:促炎细胞因子和氧化应激。
通过胰管内注入3.5%牛磺胆酸钠诱导胰腺炎。我们研究了黄嘌呤氧化酶特异性抑制剂奥昔嘌醇和/或TNF-α生成抑制剂己酮可可碱的治疗是否会影响胰腺损伤、腹水、肺部炎症和MAPK磷酸化。
奥昔嘌醇可防止胰腺中p38磷酸化,并部分避免肺髓过氧化物酶活性升高。己酮可可碱可防止胰腺中erk 1/2和JNK磷酸化,并部分减少腹水和肺髓过氧化物酶活性升高。奥昔嘌醇和己酮可可碱联合治疗几乎完全消除了腹水、胰腺中的MAPK磷酸化以及肺髓过氧化物酶活性增加。组织学检查显示胰腺和肺部损伤减轻。这些变化与生存率的显著提高相关。
同时抑制TNF-α生成和黄嘌呤氧化酶活性可大大降低急性胰腺炎的局部和全身炎症反应,并降低死亡率。这些效应与三大MAPK的阻断有关。